|1.||Strupp, Michael: 5 articles (10/2015 - 07/2013)|
|2.||Brandt, Thomas: 3 articles (04/2015 - 07/2013)|
|3.||Bremova, Tatiana: 2 articles (10/2015 - 04/2015)|
|4.||Zwergal, Andreas: 2 articles (04/2015 - 01/2015)|
|5.||Feil, Katharina: 2 articles (04/2015 - 10/2013)|
|6.||Dieterich, Marianne: 2 articles (01/2015 - 07/2013)|
|7.||Vidal, P P: 2 articles (01/2009 - 02/2001)|
|8.||Li, Quanshun: 1 article (11/2015)|
|9.||Zhang, Liu: 1 article (11/2015)|
|10.||Li, Zhiyuan: 1 article (11/2015)|
|1.||Cerebellar Ataxia (Dysmetria)
09/01/2015 - "Acetyl-DL-leucine improved cerebellar ataxia (two observational studies); it also accelerated central compensation in an animal model of acute unilateral lesion, but RCTs were negative. "
04/01/2015 - "Acetyl-dl-leucine improves cerebellar ataxia (three observational studies); it also accelerates central compensation in an animal model of acute unilateral lesion, but RCTs were negative. "
10/20/2015 - "To assess the effects of the modified amino acid acetyl-dl-leucine (AL) on cerebellar ataxia, eye movements, and quality of life of patients with Niemann-Pick type C (NP-C) disease. "
05/01/2015 - "Failure to confirm benefit of acetyl-DL-leucine in degenerative cerebellar ataxia: a case series."
10/01/2013 - "Thirteen patients (eight males, median age 51 years) with degenerative cerebellar ataxia of different etiologies (SCA1/2, ADCA, AOA, SAOA) were treated with acetyl-DL-leucine (5 g/day) without titration for 1 week. "
|2.||Acoustic Neuroma (Acoustic Neurinoma)
|3.||Body Weight (Weight, Body)
01/01/2015 - "A significant reduction of postural imbalance scores was identified on day 7 in the N-acetyl-DL-leucine (p < 0.03) and the N-acetyl-L-leucine groups (p < 0.01), compared to the sham treatment group, but not in the N-acetyl-D-leucine group (comparison for applied dose of 24 mg i.v. per rat, equivalent to 60 mg/kg body weight, in each group). "
|4.||Vertigo (Positional Vertigo)
01/01/1958 - "[Trial therapy of labyrinthine vertigo by acetyl-DL-leucine]."
01/01/2007 - "Acetylleucine is a drug that is used to treat acute vestibular vertigo. "
01/01/1957 - "[Action of acetylleucine on experimental vertigo in mice]."
01/01/2009 - "For 40 years, the amino acid acetyl-DL-leucine (or isoleucine - Tanganil) has been used in clinical practice to reduce imbalance and autonomic manifestations associated with acute vertigo crises. "
02/01/2001 - "For 40 years, the amino acid acetyl-DL-leucine (or isoleucine/Tanganil) has been used in clinical practice to reduce the imbalance and autonomic signs associated with acute vertigo crises. "
|5.||Cerebellar Diseases (Cerebellar Syndrome)
07/01/2013 - "Aminopyridine, chlorzoxazone, and acetyl-DL-leucine are new treatment options for various cerebellar diseases. "
09/01/2015 - "There are currently different groups of drugs for the pharmacotherapy of vertigo, nystagmus and cerebellar disorders: antiemetics; anti-inflammatories, antimenieres, and antimigraineous medications and antidepressants, anticonvulsants, aminopyridines as well as acetyl-DL-leucine. "
04/01/2015 - "There are currently eight groups of drugs for the pharmacotherapy of vertigo, nystagmus, and cerebellar disorders: antiemetics; anti-inflammatories, antimenieres, and antimigraineous medications; antidepressants, anticonvulsants, aminopyridines, and acetyl-DL-leucine ("the eight A's"). "
|4.||4-Aminopyridine (4 Aminopyridine)
|1.||Drug Therapy (Chemotherapy)